{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:47:45Z","timestamp":1788871665070,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.neuro.2011.03.013","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T02:19:45Z","timestamp":1303265985000},"page":"471-477","source":"Crossref","is-referenced-by-count":49,"title":["Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite"],"prefix":"10.1016","volume":"32","author":[{"given":"Lydia M.","family":"Mexas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia R.","family":"Florang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.neuro.2011.03.013_bib0005","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/nrn1434","article-title":"Oxidative stress in neurodegeneration: cause or consequence?","volume":"10","author":"Andersen","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.neuro.2011.03.013_bib0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1568007033482913","article-title":"3,4-Dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease","volume":"2","author":"Burke","year":"2003","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.neuro.2011.03.013_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0161-813X(03)00090-1","article-title":"Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases","volume":"25","author":"Burke","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2011.03.013_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","article-title":"3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis","volume":"989","author":"Burke","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2011.03.013_bib0025","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1074\/jbc.M109.054510","article-title":"A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles","volume":"285","author":"Cartier","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0030","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuro.2011.03.013_bib0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.1091","article-title":"Chronic l-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions","volume":"16","author":"Datla","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2011.03.013_bib0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/exnr.1996.6379","article-title":"Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease","volume":"144","author":"Elsworth","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ana.410360119","article-title":"Parkinson's disease and brain levels of organochlorine pesticides","volume":"36","author":"Fleming","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0050","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.1021\/bi981462g","article-title":"Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3\u00c5 resolution: self-hydroxylation of Phe300 and the pterin-binding site","volume":"37","author":"Goodwill","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuro.2011.03.013_bib0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","article-title":"Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro","volume":"14","author":"Graham","year":"1978","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4757-9480-9_13","article-title":"Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease","volume":"387","author":"Hastings","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0006-2952(79)90245-4","article-title":"Tyrosine hydroxylase: examination of conditions influencing activity in pheochromocytoma, adrenal medulla and striatum","volume":"28","author":"Hegstrand","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0741-8329(89)90076-1","article-title":"Reactions of biogenic aldehydes with hemoglobin","volume":"6","author":"Helander","year":"1989","journal-title":"Alcohol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0080","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1471-4159.1998.71041607.x","article-title":"Activation of JNK pathway and induction of apoptosis by manganese in PC12 cells","volume":"71","author":"Hirata","year":"1998","journal-title":"J Neurochem"},{"issue":"Suppl. 3","key":"10.1016\/j.neuro.2011.03.013_bib0085","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0090","series-title":"Current protocols in protein science","author":"Jimenez","year":"1998"},{"key":"10.1016\/j.neuro.2011.03.013_bib0095","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/tx800405v","article-title":"Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate","volume":"22","author":"Jinsmaa","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0100","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"Keller","year":"2002","journal-title":"Anal Chem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0105","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0891-5849(01)00726-2","article-title":"Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptotic cell death in dopaminergic cells","volume":"31","author":"Kitazawa","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neuro.2011.03.013_bib0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0891-5849(01)00484-1","article-title":"Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria","volume":"30","author":"Kristal","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neuro.2011.03.013_bib0115","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.1999.0731309.x","article-title":"Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease","volume":"73","author":"Kuhn","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0120","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U","article-title":"Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde","volume":"60","author":"Lamensdorf","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuro.2011.03.013_bib0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00500904","article-title":"Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine","volume":"327","author":"Laschinski","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00500085","article-title":"Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives","volume":"332","author":"Laschinski","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0135","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","article-title":"Dopamine covalently modifies and functionally inactivates Parkin","volume":"11","author":"LaVoie","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.neuro.2011.03.013_bib0140","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neuro.2011.03.013_bib0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/1055-8330(95)90016-0","article-title":"An endogenous dopaminergic neurotoxin: implication for Parkinson's disease","volume":"4","author":"Mattammal","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuro.2011.03.013_bib0150","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1471-4159.1971.tb03738.x","article-title":"Distribution of tyrosine hydroxylase in human and animal brain","volume":"18","author":"McGeer","year":"1971","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0155","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/tx049843k","article-title":"Metabolism of 4-hydroxy-trans-2-nonenal by central nervous system mitochondria is dependent on age and NAD+ availability","volume":"17","author":"Meyer","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.410430504","article-title":"Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions","volume":"43","author":"Murer","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0165","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","article-title":"Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis","volume":"239","author":"Nagatsu","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0170","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00702-009-0227-8","article-title":"Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines","volume":"116","author":"Nakashima","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuro.2011.03.013_bib0175","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"Nesvizhskii","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0180","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1471-4159.1987.tb05702.x","article-title":"Biogenic aldehydes in brain: on their preparation and reactions with rat brain tissue","volume":"48","author":"Nilsson","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0278-5846(86)90023-0","article-title":"Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type","volume":"10","author":"Oreland","year":"1986","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuro.2011.03.013_bib0190","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1523\/JNEUROSCI.13-09-03669.1993","article-title":"A system for characterizing cellular and molecular events in programmed neuronal cell death","volume":"13","author":"Pittman","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2011.03.013_bib0195","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/tx700248y","article-title":"Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate","volume":"20","author":"Rees","year":"2007","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0200","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/tx9000557","article-title":"Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol","volume":"22","author":"Rees","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0205","first-page":"757","article-title":"Effects of Aroclor 1254 on dopamine and norepinephrine concentrations in pheochromocytoma (PC-12) cells","volume":"10","author":"Seegal","year":"1989","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2011.03.013_bib0210","first-page":"473","article-title":"Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies","volume":"12","author":"Shafer","year":"1991","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2011.03.013_bib0215","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C","article-title":"Cytotoxic and genotoxic potential of dopamine","volume":"55","author":"Stokes","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuro.2011.03.013_bib0220","doi-asserted-by":"crossref","first-page":"41525","DOI":"10.1074\/jbc.M203767200","article-title":"Overexpression of the protein phosphatase 2A regulatory subunit Bgamma promotes neuronal differentiation by activating the MAP kinase (MAPK) cascade","volume":"277","author":"Strack","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2011.03.013_bib0225","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/0006-2952(81)90598-0","article-title":"Enzymology and subcellular localization of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4-dihydroxyphenylacetic acid","volume":"30","author":"Tank","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0230","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0006-2952(65)90103-6","article-title":"Inhibitors of purified beef adrenal tyrosine hydroxylase","volume":"14","author":"Udenfriend","year":"1965","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0235","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/0006-2952(73)90050-6","article-title":"Inhibition of binding of aldehydes of biogenic amines in tissues","volume":"22","author":"Ungar","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2011.03.013_bib0240","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F","article-title":"Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase","volume":"54","author":"Xu","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuro.2011.03.013_bib0245","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neuint.2010.06.021","article-title":"Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells","volume":"57","author":"Zhang","year":"2010","journal-title":"Neurochem Int"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X1100060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X1100060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:48:57Z","timestamp":1741132137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X1100060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0161813X1100060X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2011.03.013","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}